Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients.

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	ĎURINÍKOVÁ Anna FOLTA Adam PARDY Filip SVATOŇ Jan DRNCOVÁ Marie WEINBERGEROVÁ Barbora CETKOVSKY Petr RÁČIL Zdeněk JINDRA Pavel SZOTKOWSKI Tomas ZAK Pavel MAYER Jiří JEŽÍŠKOVÁ Ivana
Year of publication	2022
Type	Article in Periodical
Magazine / Source	LEUKEMIA & LYMPHOMA
MU Faculty or unit	Central European Institute of Technology
Citation
Web	https://www.tandfonline.com/doi/abs/10.1080/10428194.2022.2116931?journalCode=ilal20
Doi	http://dx.doi.org/10.1080/10428194.2022.2116931
Keywords	RAS MUTATIONAMLGENE
Attached files	Single_and_multiple_point_NRAS_mutations_in_acute_myeloid_leukemia_a_study_of_327_well_molecularly_characterized_patients.pdf
Description	Oncogenic mutation in the NRAS are carried by 10-22% acute myeloid leukemia (AML) patients and represents one of the most commonly detected molecular aberrations in AML.
Related projects:	Národní program studia mutací a klonality leukemických buněk u pacientů s akutní myeloidní leukémií National Center for Medical Genomics Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX